Isabelle Billet's most recent trade in Axogen Inc. was a trade of 1,150 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 27, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2022 | 1,150 | 0 | - | - | Restricted Stock Units | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2022 | 1,150 | 25,392 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.44 per share. | 27 Dec 2022 | 327 | 25,065 (0%) | 0% | 9.4 | 3,087 | Common Stock |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2022 | 2,571 | 24,340 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Sale or transfer of securities back to the company at price $ 8.40 per share. | 18 Jul 2022 | 751 | 24,242 (0%) | 0% | 8.4 | 6,308 | Common Stock |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 23,354 | 23,354 | - | - | Restricted Stock Units | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 21,784 | 21,784 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 8,500 | 24,216 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2022 | 8,500 | 8,500 | - | - | Restricted Stock Units | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.97 per share. | 16 Mar 2022 | 2,447 | 21,769 (0%) | 0% | 8.0 | 19,503 | Common Stock |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,325 | 16,163 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.42 per share. | 15 Feb 2022 | 447 | 15,716 (0%) | 0% | 8.4 | 3,764 | Common Stock |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2021 | 1,150 | 1,150 | - | - | Restricted Stock Units | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Dec 2021 | 1,150 | 14,510 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.74 per share. | 27 Dec 2021 | 326 | 14,184 (0%) | 0% | 9.7 | 3,175 | Common Stock |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2021 | 2,572 | 14,088 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.20 per share. | 19 Jul 2021 | 728 | 13,360 (0%) | 0% | 19.2 | 13,978 | Common Stock |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 23,500 | 23,500 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2021 | 11,800 | 11,800 | - | - | Restricted Stock Units | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 1,325 | 11,534 (0%) | 0% | 0 | Common Stock | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.71 per share. | 16 Feb 2021 | 454 | 11,080 (0%) | 0% | 18.7 | 8,494 | Common Stock |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Dec 2020 | 2,300 | 10,145 (0%) | 0% | - | Common Stock | |
| Axogen Inc. | Isabelle Billet | Chief Strategy and BD Officer | Sale of securities on an exchange or to another person at price $ 17.81 per share. | 27 Dec 2020 | 649 | 9,496 (0%) | 0% | 17.8 | 11,559 | Common Stock |